Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Mukka Proteins IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2010 Industry: Animal Feed Listed Page

Profile
Issue Size --
Profile
Price Range 26  to  28 per share
Profile
Min Investment ₹28
Profile
Lot Size 1
Profile
Face Value ₹1
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Mukka Proteins Ltd is a cutting-edge biotechnology company specializing in the production of plant-based proteins. Leveraging innovative technology, the company focuses on developing sustainable and high-quality protein sources to meet the growing demand for alternative protein solutions. With a commitment to environmental stewardship, Mukka Proteins employs advanced processing methods to extract proteins from various plant sources, contributing to a more eco-friendly and ethical food industry. Their diverse product portfolio caters to the evolving needs of consumers seeking plant-based alternatives, positioning Mukka Proteins as a key player in the global shift towards sustainable and cruelty-free protein consumption. Read More

Basic Info

Face Value 1 per share

Price 26  to  28 per share

P/E (x) 17.5

Sales( Cr.) 1006

PAT( Cr.) 48

EPS 1.6

Draft Prospectus --

Exchange BSE-NSE

Promoter

Company Promoters

Kalandan Mohammed Haris Kalandan Mohammad Arif Kalandan Mohammed Althaf

Pre Issue Share Holding 100%

Post Issue Share Holding --%

Listing Details:

Listing Price: 44

Listing Gain: 36.36%

Current Price: 22.8

Gain On Issue: 22.8 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Feb 29, 2024
Closing Date Mar 04, 2024
Allotment Mar 05, 2024
Refund Mar 06, 2024
Delivery of Shares Mar 06, 2024
Listing Date Mar 07, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 535 14,980
Retail (Max) 13 6955 194,740
S-HNI (Min) 14 7490 209,720
S-HNI (Max) 66 35310 988,680
B-HNI (Min) 67 35845 1,003,660

Objective of the Issue

1. Funding working capital requirements of the Company 2. Investment in the Associate, viz. Ento Proteins Private Limited, for funding its working capital requirements 3. General Corporate Purposes.

Issue

Category Nos Bid Bid (x)
QIB 40000000 7571200000 189.3x
NII 12000000 3004680000 250.4x
Retail 28000000 1638560000 58.5x
EMP 0 0 0x
Total 80000000 10959200000 137x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Mukka Proteins Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 409 549 604 771 1177 1380 1006
Other Income 3 8 10 7 7 17 15
Total Income 412 557 614 778 1184 1397 1022
Total Expenditure 385 525 582 724 1091 1274 912
Operating Profit 26 32 32 54 93 123 110
Interest 4 7 8 10 16 26 37
Depreciation 2 5 8 9 12 12 14
Exceptional Income / Expenses -1 0 0 0 0 0 0
Profit Before Tax 19 20 15 36 66 87 60
Provision for Tax 5 6 4 10 18 13 12
Profit After Tax 14 14 11 26 48 74 48
Adjustments 1 -0 -2 -2 -3 -4 -2
Profit After Adjustments 14 13 9 24 44 70 46
Adjusted Earnings Per Share 0.6 0.6 0.4 1.1 2 2.3 1.5

Mukka Proteins Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 44 57 67 98 148 396 441
Minority's Interest 0 1 3 5 8 12 16
Borrowings 16 14 9 9 5 6 3
Other Non-Current Liabilities 3 4 4 6 11 5 7
Total Current Liabilities 137 217 272 274 403 521 610
Total Liabilities 201 293 355 392 575 941 1076
Fixed Assets 48 77 78 81 83 84 93
Other Non-Current Assets 11 10 20 25 28 41 58
Total Current Assets 142 206 257 286 464 817 926
Total Assets 201 293 355 392 575 941 1076

Mukka Proteins Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 10 1 1 3 12 27 94
Cash Flow from Operating Activities -20 -25 2 5 -56 -150 -112
Cash Flow from Investing Activities -23 -28 -14 -11 -3 -48 -35
Cash Flow from Financing Activities 34 54 13 15 75 266 56
Net Cash Inflow / Outflow -9 1 2 8 15 68 -91
Closing Cash & Cash Equivalent 1 2 3 12 27 94 3

Mukka Proteins Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.65 0.6 0.41 1.1 2 2.34 1.55
CEPS(Rs) 0.73 0.83 0.88 1.56 2.7 2.89 2.05
DPS(Rs) 0 0 0 0 0 0 0
Book NAV/Share(Rs) 2 2.57 3.02 4.47 6.72 13.2 14.69
Core EBITDA Margin(%) 5.71 4.33 3.62 6.07 7.11 7.49 9.25
EBIT Margin(%) 5.66 4.9 3.89 5.93 6.8 8.06 9.5
Pre Tax Margin(%) 4.6 3.59 2.56 4.67 5.44 6.21 5.87
PAT Margin (%) 3.35 2.47 1.82 3.35 3.92 5.28 4.69
Cash Profit Margin (%) 3.94 3.33 3.21 4.46 4.9 6.16 6.01
ROA(%) 6.81 5.5 3.4 6.91 9.82 9.8 4.77
ROE(%) 31.1 27 17.89 31.32 38.61 27.32 11.5
ROCE(%) 18.24 16.57 11.08 18.35 24.44 19.54 11.82
Receivable days 25.44 21.1 25.05 25.87 26.3 38.72 68.51
Inventory Days 80.39 68.16 80.08 74.55 59.45 84.67 175.65
Payable days 62.95 54.51 64.49 56.82 44.27 42.92 65.49
PER(x) 0 0 0 0 0 15.62 21.12
Price/Book(x) 0 0 0 0 0 2.76 2.23
Dividend Yield(%) 0 0 0 0 0 0 0
EV/Net Sales(x) 0.21 0.26 0.27 0.24 0.21 0.96 1.38
EV/Core EBITDA(x) 3.33 4.6 5.04 3.35 2.67 10.84 12.63
Net Sales Growth(%) 0 34.36 9.94 27.6 52.77 17.22 -27.06
EBIT Growth(%) 0 16.41 -12.85 94.49 80.51 37.59 -14.01
PAT Growth(%) 0 -0.78 -18.89 134.5 84.07 56.35 -35.27
EPS Growth(%) 0 -7.8 -31.88 169.71 82.06 16.56 -33.68
Debt/Equity(x) 1.88 2.51 2.39 1.76 1.72 0.91 1.02
Current Ratio(x) 1.04 0.95 0.95 1.05 1.15 1.57 1.52
Quick Ratio(x) 0.38 0.42 0.39 0.44 0.58 0.75 0.59
Interest Cover(x) 5.33 3.74 2.93 4.72 5 4.37 2.62
Total Debt/Mcap(x) 0 0 0 0 0 0.33 0.46

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -27% 9% 13% 0%
Operating Profit CAGR -11% 27% 28% 0%
PAT CAGR -35% 23% 28% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -26% NA% NA% NA%
ROE Average 12% 26% 25% 26%
ROCE Average 12% 19% 17% 17%

Company Contact Information

Mukka Proteins Ltd.

Mukka Corporate House Door No. 18-2-16/4, First Cross N G Road, Attavara, Dakshina Kannada

IPO Lead Manager(s)

Mukka Proteins Ltd.

Fedex Securities Ltd.

Registrar Info

Mukka Proteins Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!